Phase 1Completed
Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)
A Phase 1, Open-Label Study to Evaluate the Effect of AT-527 on the Pharmacokinetics of Digoxin in Healthy Adult Subjects
- Sponsor
- Atea Pharmaceuticals, Inc. (Industry)
- Enrollment
- 29 enrolled
- Conditions
- Healthy Volunteers Study
- Interventions
- AT-527 + digoxin; AT-527 + digoxin
- Ages
- adults
- Registry
- NCT05137626
Full record on ClinicalTrials.gov
From the registry
Drug-drug interaction study of Digoxin and AT-527 (R07496998)
Primary outcomes
- To determine the effect of AT-527 on the single-dose pharmacokinetics (PK) of digoxin
- To determine the effect of a staggered dose of AT-527 administered 2 hours before digoxin on the PK of digoxin
History
Last registry update
Primary completion
Registered
Started